Literature DB >> 15189452

Dok-1 tyrosine residues at 336 and 340 are essential for the negative regulation of Ras-Erk signalling, but dispensable for rasGAP-binding.

Hisaaki Shinohara1, Tomoharu Yasuda, Yuji Yamanashi.   

Abstract

Dok-1 is a common substrate of many protein tyrosine kinases (PTKs). It recruits rasGAP and other SH2-containing proteins and negatively regulates Ras-Erk signalling downstream of PTKs. However, the mechanisms of its inhibitory effect are yet unclear. Here, a series of C-terminal deletion mutants of Dok-1 delineated the core domain for the inhibition of Erk from 334 to 346 amino acid, which contains two SH2-binding motifs having Tyr-336 or Tyr-340. The Dok-1 mutants having tyrosine-to-phenylalanine (YF) substitution(s) at Tyr-336 and/or Tyr-340 lost their inhibitory effect on Ras and Erk downstream of Src-like PTK, Lyn or Fyn, whereas the rasGAP-binding of each mutant remained intact. However, the Dok-1 mutant having YF substitutions at the rasGAP-binding sites (Tyr-295 and Tyr-361) also showed incapability of Ras and Erk inhibition. Moreover, the Dok-1 mutant having YF substitutions at Tyr-336 and Tyr-340 showed an impaired inhibitory effect on v-Abl-induced transformation of NIH-3T3 cells. These results demonstrate that Tyr-336 and Tyr-340 of Dok-1 are dispensable for rasGAP-binding but essential for inhibition of Ras-Erk signalling and cellular transformation downstream of PTKs. Thus, Dok-1 probably recruits as yet unidentified molecule(s), which, in concert with rasGAP, negatively regulate Ras-Erk signalling. Copyright Blackwell Publishing Limited

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15189452     DOI: 10.1111/j.1356-9597.2004.00748.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  11 in total

1.  Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis.

Authors:  Mingming Zhao; Justyna A Janas; Masaru Niki; Pier Paolo Pandolfi; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

2.  Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.

Authors:  Justyna A Janas; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

3.  Divergent roles of c-Src in controlling platelet-derived growth factor-dependent signaling in fibroblasts.

Authors:  Kavita Shah; Fabien Vincent
Journal:  Mol Biol Cell       Date:  2005-08-31       Impact factor: 4.138

4.  A concerted kinase interplay identifies PPARgamma as a molecular target of ghrelin signaling in macrophages.

Authors:  Annie Demers; Véronique Caron; Amélie Rodrigue-Way; Walter Wahli; Huy Ong; André Tremblay
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

5.  Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events.

Authors:  Debbie L Cunningham; Steve M M Sweet; Helen J Cooper; John K Heath
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

6.  An essential regulatory role of downstream of kinase-1 in the ovalbumin-induced murine model of asthma.

Authors:  Chang-Min Lee; In Duk Jung; Kyung Tae Noh; Jun Sik Lee; Jin Wook Park; Deok Rim Heo; Jun Ho Park; Jeong Hyun Chang; Il-Whan Choi; Jong-Suk Kim; Yong Kyoo Shin; Sung-Joo Park; Myung-Kwan Han; Chun Geun Lee; Won-Kyung Cho; Yeong-Min Park
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

7.  Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling.

Authors:  Hisaaki Shinohara; Akane Inoue; Noriko Toyama-Sorimachi; Yoshinori Nagai; Tomoharu Yasuda; Hiromi Suzuki; Reiko Horai; Yoichiro Iwakura; Tadashi Yamamoto; Hajime Karasuyama; Kensuke Miyake; Yuji Yamanashi
Journal:  J Exp Med       Date:  2005-02-07       Impact factor: 14.307

8.  Phosphorylation of Dok1 by Abl family kinases inhibits CrkI transforming activity.

Authors:  K Y Ng; T Yin; K Machida; Y I Wu; B J Mayer
Journal:  Oncogene       Date:  2014-07-21       Impact factor: 9.867

9.  Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer.

Authors:  Teresa Friedrich; Michaela Söhn; Tobias Gutting; Klaus-Peter Janssen; Hans-Michael Behrens; Christoph Röcken; Matthias P A Ebert; Elke Burgermeister
Journal:  EBioMedicine       Date:  2016-05-05       Impact factor: 8.143

10.  The right and wrong of DOKing the nuclear receptor.

Authors:  Igor Astsaturov
Journal:  EBioMedicine       Date:  2016-05-28       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.